Catalyst Wire Dossier Catalyst Wire Dossier

Garetosmab

Garetosmab · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Garetosmab, covering 2021-11-01 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) [Phase 3]

See pricing